
WB analysis of human spleen lysate using GTX89082 SLC7A11 antibody, Internal. Dilution : 0.02microg/ml Loading : 35microg protein in RIPA buffer
xCT / SLC7A11 antibody, Internal
GTX89082
ApplicationsWestern Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityHuman, Rat
TargetSLC7A11
Overview
- SupplierGeneTex
- Product NamexCT / SLC7A11 antibody, Internal
- Delivery Days Customer7
- Application Supplier NoteWB: 0.02-0.06microg/ml. IHC-P: 3.75microg/ml. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsWestern Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration0.50 mg/ml
- ConjugateUnconjugated
- Gene ID23657
- Target nameSLC7A11
- Target descriptionsolute carrier family 7 member 11
- Target synonymsamino acid transport system xc-; calcium channel blocker resistance protein CCBR1; CCBR1; cystine/glutamate transporter; solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11; solute carrier family 7, (cationic amino acid transporter, y+ system) member 11; xCT
- HostGoat
- IsotypeIgG
- Protein IDQ9UPY5
- Protein NameCystine/glutamate transporter
- Scientific DescriptionThis gene encodes a member of a heteromeric, sodium-independent, anionic amino acid transport system that is highly specific for cysteine and glutamate. In this system, designated Xc(-), the anionic form of cysteine is transported in exchange for glutamate. This protein has been identified as the predominant mediator of Kaposi sarcoma-associated herpesvirus fusion and entry permissiveness into cells. Also, increased expression of this gene in primary gliomas (compared to normal brain tissue) was associated with increased glutamate secretion via the XCT channels, resulting in neuronal cell death. [provided by RefSeq, Sep 2011]
- ReactivityHuman, Rat
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- Increased Expression of System xc- in Glioblastoma Confers an Altered Metabolic State and Temozolomide Resistance. Polewski MD et al., 2016 Dec, Mol Cancer ResRead more